Key Takeaways Opendoor’s stock has shown signs of stabilisation, trading above its volume-weighted average price (VWAP) in late July 2025, but faces technical resistance at its 50-day moving average. Operationally,...
Key Takeaways The US House Judiciary Committee has launched an investigation into Spotify’s content moderation policies, citing concerns over potential censorship and suppression of free speech. Spotify’s spending on content...
Key Takeaways Sequans Communications holds a Bitcoin treasury valued at approximately $364 million, a figure that surpasses its market capitalisation of $236 million. The company’s core business in IoT semiconductors...
Key Takeaways A potential acquisition of CyberArk by Palo Alto Networks for over $20 billion highlights a significant consolidation trend within the cybersecurity industry. The proposed deal underscores the growing...
Key Takeaways The tokenization of US stocks on blockchains such as Ethereum is gaining momentum, aiming to improve liquidity and accessibility through fractional ownership and continuous, 24/7 trading. Major trading...
Key Takeaways Apple is set to close a retail store in mainland China for the first time, a move prompted by declining sales, intense local competition, and a broader economic...
Key Takeaways JPMorgan Chase is in advanced discussions to take over Apple’s credit card programme from Goldman Sachs, marking a significant strategic shift in consumer finance. The potential move highlights...
Key Takeaways Snow Lake Resources has pivoted its strategy from lithium to focus on uranium, rare earth elements, and antimony, aligning with growing global demand for critical minerals. The company...
Key Takeaways BitMine Immersion Technologies has announced a substantial share repurchase programme of up to USD 1 billion, signalling confidence in its stock’s undervaluation relative to its net asset value....
Key Takeaways Novo Nordisk has revised its 2025 financial guidance downwards, citing slower-than-expected growth for its key drugs Wegovy and Ozempic due to production bottlenecks and rising competition. The market...
